Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
NVIDIA (NVDA) PT Raised to $150 at Argus, 'We recommend establishing or adding to positions'
-
NVIDIA (NVDA) PT Raised to $1,100 at Argus
-
NVIDIA (NVDA) PT Raised to $950 at Argus
-
Nvidia briefly joins $1 trillion valuation club
-
UPDATE: NVIDIA (NVDA) PT Raised to $340 at Argus
-
NVIDIA (NVDA) PT Raised to $280 at Argus; Reiterates Buy
-
NVIDIA (NVDA): Selloff Overdone, Reiterate Buy - Argus
-
NVIDIA (NVDA) PT Raised to $175 at Argus; Valuation Not too Stretched
-
Pre-Open Stock Movers 12/30: (MRNS) (ICON) (MYL) Higher; (INNL) (OPK) (CAB) Lower (more...)
-
Pre-Open Stock Movers 12/28: (LIVE) (GALE) (OCRX) Higher; (ANTH) (QCOM) Lower (more...)
-
NVIDIA (NVDA) PT Raised to $130 at Argus; Sees Further Upside
-
Notable 52-Week Highs and Lows 3/18: (DFT) (ADBE) (NVDA) High; ((HTBX) ((SGYP) (RH) Low
-
Notable Analyst Rating Changes 3/18: (SEAS) (TOT) (CUDA) Upgraded; (KMT) (IRBT) (NDRO) Downgraded
-
Argus Starts NVIDIA (NVDA) at Buy
-
Notable Analyst Rating Changes 05/07: (TXN) (GRPN) (PEP) Upgraded; (MELI) (CCL) (PG) Downgraded
-
Notable Analyst Rating Changes 09/01: (CTSH) (DYN) (ACI) Upgraded; (RPM) (BAH) (GS) Downgraded
-
Notable Analyst Rating Changes 05/31: (GS) (NVDA) (TZOO) Upgraded; (GSK) (MDT) (TASR) Downgraded
-
Notable Analyst Rating Changes 01/28: RAX, NVDA, GE, BPZ Upgraded; T, INFN, THOR, AMZN Downgraded
-
Notable Analyst Rating Changes 11/12: ETN, NVDA, LDK, AH Upgraded; BA, STZ, NBL, MO Downgraded
-
Notable Analyst Rating Changes 11/05: NVDA, AXP, PCS, TC Upgraded; BIG, PT, CLWR, WPRT Downgraded
-
David Moenning's Daily State of the Markets: 5/8
-
David Moenning's Daily State of the Markets: 4/28
-
Morning Movers 1/13: ZymoGenetics (ZGEN) Up On Bristol-Myers Deal; Lexmark (LXK) Down On Guidance

